INVO Fertility (IVF) Share-based Compensation Growth (1y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 31.63% |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 | 410.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 410.33% |
| Jun 30, 2025 | 19,367.21% |
| Mar 31, 2025 | 76,698.91% |
| Dec 31, 2024 | 66.08% |
| Sep 30, 2024 | -68.31% |
| Jun 30, 2024 | 100.07% |
| Mar 31, 2024 | -99.97% |
| Dec 31, 2023 | -151.05% |
| Sep 30, 2023 | 730.57% |
| Jun 30, 2023 | 18.29% |
| Mar 31, 2023 | -23.96% |
| Dec 31, 2022 | 252.64% |
| Sep 30, 2022 | -9.59% |
| Jun 30, 2022 | -126.02% |
| Mar 31, 2022 | 13.80% |
| Dec 31, 2021 | -374.11% |
| Sep 30, 2021 | -66.13% |
| Jun 30, 2021 | 598.23% |
| Mar 31, 2021 | -1.30% |
| Dec 31, 2020 | 313.83% |
| Dec 31, 2019 | 104.00% |
| Dec 31, 2018 | -2,301.29% |
| Jun 30, 2018 | 3,147.05% |
| Mar 31, 2018 | 206.65% |
| Jun 30, 2017 | -96.19% |
| Dec 31, 2015 | -92.18% |
| Jun 30, 2013 | -2.46% |